Starling Surgical

Starling Surgical is a private Irish medtech company developing a surgical wound-closure device intended to combine the speed and convenience of skin staplers with the clinical benefits of suturing. Its lead product, QuickStitch, is designed for post-operative incision closure and aims to improve consistency, reduce infection risk and pain associated with staples, and improve cosmetic outcomes. The company emerged from Trinity College Dublin and has been described as a spin-out supported by EIT Health and MedTech Innovator. Publicly available information indicates the company remains active, but there is limited recent disclosure on regulatory approvals or commercial launch. Overall, Starling Surgical appears to be an early-stage medical device developer focused on improving surgical closure workflow and outcomes.